| |
Home : Z : Zafirlukast : Zafirlukast and Erythromycin
Effects and Recommendation :
Erythromycin may decrease the bioavailability of Zafirlukast.
Monitor patient response and adjust ZAFIRLUKAST dose accordingly.
Severity of the interaction : 3/6
|
Information on this interaction is found in the following publications :
----------
Product Information. Zafirlukast (Accolate). AstraZeneca, March 1999.
Publication : Zafirlukast (Accolate) by Product Information
> Product Information - -
|
|
|
|
|
